.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

COVID-19

Nirmatrelvir-Ritonavir Highly Effective at Preventing COVID-19 Hospitalization, RWE Says

November 26th 2022, 10:00pm

Article

The study of real-world evidence (RWE) found nearly 9 in 10 patients in a highly vaccinated cohort avoided hospitalization within 15 days of treatment for COVID-19.

Nirmatrelvir-Ritonavir Shows Safety, Efficacy in Real-world Study of High-risk COVID-19 Patients

November 23rd 2022, 10:31pm

Article

The retrospective study evaluated outcomes in patients prescribed nirmatrelvir-ritonavir, as well as the management of drug interactions by clinical pharmacists prescribing the regimen.

Researchers Point to IL-26 as Biomarker of Severe COVID-19

November 19th 2022, 1:39am

Article

High levels of interleukin (IL)-26 levels correlate with an exaggerated inflammatory response that signifies severe cases of the disease, according to researchers.

Contributor: COVID-19 Fell in Rank Among Telehealth Diagnoses in South and West in August 2022

November 11th 2022, 5:10pm

Article

Telehealth diagnoses in the South and West regions of the United States saw a reduction in COVID-19 diagnoses.

What We’re Reading: Listeria Outbreak; COVID-19 Death Decline; Eli Lilly Pays in Drug Patent Trial

November 10th 2022, 2:41pm

Article

A listeria outbreak has been linked to deli meats and cheeses; the World Health Organization announced that there has been a 90% drop in recent deaths in COVID-19 globally compared with 9 months ago; Eli Lilly was ordered to pay $176.5 million in a US migraine drug patent trial.

What We’re Reading: VA to Prioritize Cancer Claims; Pfizer’s COVID-19 Cash; Medicaid Coverage Concerns

November 8th 2022, 2:40pm

Article

The Department of Veterans Affairs (VA) will give cancer claims priority when a new law takes effect in January 2023; Pfizer is looking to use its COVID-19 profits to grow other blockbusters; the probable loss of Medicaid coverage for millions next year is setting off debate.

Contributor: COVID-19 Ranked Among the Top 5 Telehealth Diagnoses Nationally in April 2022

July 6th 2022, 12:30pm

Article

COVID-19 was ranked in the top 5 diagnoses through telehealth in the Midwest, Northeast, and West regions as well as nationally in the month of April, coinciding with an increase in COVID-19 cases.

What’s Next in Health Care? Panelists Highlight Data, Partnerships Post-COVID-19

June 24th 2022, 5:39pm

Article

Panelists of an AHIP 2022 session discussed how future policy, infrastructure, and investment strategies in public health will reinforce the efforts already made during the pandemic, with partnerships and engagement key to optimize innovation.

Contributor: COVID-19 Falls Out of Top 5 Telehealth Diagnoses in February 2022

May 9th 2022, 4:15pm

Article

The February drop out of the top 5 coincided with a sharp decline in new cases of COVID-19, as reported by the CDC, following the January peak of the wave of cases related to the Omicron variant.

Telehealth at Minnesota Oncology: Tackling COVID-19, Educating Patients, and Overcoming the Weather

February 14th 2022, 9:00pm

Article

Rajini Katipamula-Malisetti, MD, a medical oncologist and hematologist with Minnesota Oncology who practices in Coon Rapids, has seen telehealth’s usefulness up close. During a pandemic, it can increase the number of touch points in areas such as survivorship care and nutrition, which would otherwise require a separate visit to the office.